Hearing Loss, Sensorineural Clinical Trial
— OtiSOfficial title:
Learning to Listen in Noise: A Double-blind Randomized Control Trial of a New Hearing Aid Noise Reduction System
Verified date | January 2020 |
Source | Children's Hospital Medical Center, Cincinnati |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to evaluate the efficacy of OpenSound Navigator (OSN), a hearing aid speech-enhancement algorithm developed by Oticon, as treatment for pediatric hearing aid users. Using a double-blind experimental design, the investigators aim to compare two treatment groups of pediatric (ages 6-12) patients with symmetrical sensorineural hearing losses ranging from the mild to moderately-severe degree. One group will be fit with bilateral Oticon OPN™ behind-the-ear hearing aids set with an omni-directional microphone setting. The other group will be fit with the same hearing aid model with the OSN algorithm enabled. Participants from the groups will be age and audiogram-matched. The investigators will evaluate hearing aid benefit through word recognition in noise (behavioral testing) and everyday hearing/listening abilities (parental/legal guardian reported) at hearing aid fitting and 6-8 months post fitting.
Status | Completed |
Enrollment | 40 |
Est. completion date | August 30, 2020 |
Est. primary completion date | July 30, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 6 Years to 13 Years |
Eligibility | Inclusion Criteria: - children ages 6 to 13 years - English as the primary home language - positive for bilateral symmetrical mild to moderately-severe sensorineural hearing loss - currently using hearing aids that were dispensed at least 18 months prior to enrollment of the study - negative for major cognitive handicap or developmental delay that would prevent or restrict participation, as determined by the PI or designee - negative for learning disability, for example attention-deficit/hyperactivity disorder, as determined by the PI or designee - negative for serious neurological or psychiatric disease that would prevent or restrict participation, as determined by the PI or designee - informed consent of parent/guardian - assent of participating child if aged 11 years and over - standard MRI inclusion criteria as set by the Cincinnati Children's Hospital Medical Center department of Radiology - not currently pregnant or breast feeding - willingness and ability of the participant and/or the participant's caregiver to comply with study requirements - no history of medical neglect of caregiver |
Country | Name | City | State |
---|---|---|---|
United States | Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio |
Lead Sponsor | Collaborator |
---|---|
Children's Hospital Medical Center, Cincinnati | Oticon |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from Baseline Word Recognition Abilities at 6 to 8 Months | Aided speech perception in noise within a week of hearing aid fitting and again 6-8 months later. | 6-8 months | |
Secondary | Change from Baseline Speech, Spatial Qualities of Hearing Scale (SSQ) Scores at 6 to 8 Months | Speech, Spatial and Qualities of Hearing Scale (SSQ), a survey utilizing an ordinal scale specifically measuring hearing aid benefit with regard to speech understanding, spatial awareness, perceptual quality of sound, and conversation, will be completed by parents/legal guardian within a week of the hearing aid fitting and after wearing the study hearing aids for 6-8 months. There are 4 survey sections. Section A: Speech has 8 questions, Section B: Spatial Hearing has 5 questions, Section C: Qualities of Hearing has 8 questions and Section D: Conversational Uses of Hearing has 5 questions. Each question uses a scale ranging from 0 (poorest possible outcome) to 100 (best possible outcome). Each section calculates an average score across the corresponding questions for a total of 4 individual scores. | 6-8 months | |
Secondary | Hearing aid use time | Average daily use of hearing aids. | 6-8 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04281953 -
Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
|
||
Not yet recruiting |
NCT05973669 -
MED-EL Remote Care Multi-Center Feasibility Study
|
N/A | |
Completed |
NCT04601909 -
FX-322 in Adults With Age-Related Sensorineural Hearing Loss
|
Phase 1 | |
Active, not recruiting |
NCT04479761 -
Sensory Integration of Auditory and Visual Cues in Diverse Contexts
|
N/A | |
Recruiting |
NCT05043207 -
A Study Protocol for the Validation of UAud in a Clinical Setting.
|
N/A | |
Recruiting |
NCT04070937 -
Correlation of Radiological Lesions With Vestibular Function in Patients With Bilateral Vestibulopathy
|
||
Recruiting |
NCT04066270 -
Inventory of Radiological and Vestibular Function in Cochlear Implant Candidates
|
||
Completed |
NCT03512951 -
Subjective Evaluation of a Sound Processing Method for Hearing Aids on Auditory Distance Perception
|
N/A | |
Completed |
NCT05855005 -
Direct-to-Consumer Hearing Aids and Listening Effort
|
N/A | |
Recruiting |
NCT05599165 -
Speech Perception in Bimodal Hearing
|
N/A | |
Completed |
NCT05101083 -
Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids
|
N/A | |
Completed |
NCT05521308 -
Investigating Hearing Aid Frequency Response Curves
|
N/A | |
Completed |
NCT05072457 -
Benefit of Assistive Listening Device for Lateralization
|
N/A | |
Recruiting |
NCT05776459 -
Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
|
Phase 2 | |
Completed |
NCT05086276 -
FX-322 in Adults With Acquired Sensorineural Hearing Loss
|
Phase 2 | |
Recruiting |
NCT06058767 -
Preschool Hearing Screening
|
N/A | |
Completed |
NCT05180630 -
Sound Quality Comparisons With Different Hearing Aid Couplings and Venting Systems
|
N/A | |
Completed |
NCT03613909 -
Acceptance of the CP950 Sound Processor
|
N/A | |
Active, not recruiting |
NCT03352154 -
Long Latency Auditory Evoked Potentials (P300) Outcomes in Patients With Unilateral Cochlear Implants
|
N/A | |
Completed |
NCT04629664 -
FX-322 in Adults With Severe Sensorineural Hearing Loss
|
Phase 1 |